Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma
- PMID: 37317959
- DOI: 10.1002/ajh.26995
Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma
References
REFERENCES
-
- Rasche L, Chavan SS, Stephens OW, et al. Spatial genomic hetero- geneity in multiple myeloma revealed by multi-region sequencing. Nat Commun. 2017;8:1-11.
-
- Charalampous C, Kourelis T. Minimal residual disease assessment in multiple myeloma patients: minimal disease with maximal implications. Front Oncol. 2022;11:801851.
-
- Rasche L, Alapat D, Kumar M, et al. Combination of flow cytom- etry and functional imaging for monitoring of residual disease in myeloma. Leukemia. 2019;33:1713-1722.
-
- Mina R, Bonello F, Oliva S. Minimal residual disease in multiple myeloma: ready for prime time? Cancer J. 2021;27(3):247-255.
-
- Messiou C, Hillengass J, Delorme S, et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology. 2019;291:5-13.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
